Innovation
Active Fabric Technology: The Solution
Bi-directional Clinical Loop
Our smart, soft, and washable active fabric delivers software-controlled tactile stimuli while simultaneously measuring patient responses in real-time. This creates a complete feedback loop between clinician and patient.
Fabtive enables scalable, data-driven, and personalized tactile therapy that transforms how healthcare professionals deliver remote treatment.
*. Images are for illustrative purposes only. Final product design may vary.
Scalable
Deploy therapeutic touch interventions across unlimited patient populations without geographical constraints.
Data-Driven
Real-time measurement and analysis of patient responses enables evidence-based treatment optimization.
Personalized
Software-controlled stimuli adapt to individual patient needs and therapeutic protocols dynamically.
The 2026 RTM Window: Turning Clinical Care into Scalable Revenue
Why Now? The 2026 CMS Paradigm Shift For the first time, new CMS regulations (Jan 2026) authorize reimbursement for short-cycle (2-15 days) remote therapeutic monitoring. This creates a high-margin revenue stream for clinics using Plectrum’s RTM-ready platform.
- Immediate ROI: Hardware costs covered within 3–4 months.
- Scalable Income: $120–$200 recurring
- monthly revenue per patient.
- Proven Compliance: Automated data logs for seamless billing.
Source: Figures based on CMS CY 2026 Physician Fee Schedule (PFS) National Average. Actual reimbursement rates may vary based on geographic location (GPCI adjustments), provider specialty, and individual private payer contracts.
The Scalability Edge: From Patient Care to Practice Growth
Our AI-driven platform doesn’t just improve clinical outcomes; it transforms your practice's unit economics. By automating the data collection required for RTM, Plectrum allows providers to scale their patient reach without increasing administrative overhead.
- Compound Revenue: As your patient base grows, the RTM framework creates a predictable, high-margin recurring income.
- Operational Efficiency: Automated documentation ensures a 95% claims approval rate, minimizing the "denial gap" typical of manual remote monitoring.
- Future-Proofing: Partners joining today secure priority access to our next-generation Fabtive active fabric protocols.
Calculated based on CMS CY 2026 National Physician Fee Schedule. Actual reimbursement amounts are subject to geographic adjustment factors (GPCI) and specific payer contracts.
Sources: CMS Final Rule - CY 2026 Updates ; CMS.gov - Physician Fee Schedule ; Federal Register - Medicare Program Changes
Clinical Excellence
Validated by Leading Medical Institution
*. LOI Signed
Hadassah Medical Center Accelerator
Plectrum is a graduate of the Hadassah Medical Center Accelerator, powered by IBM. During the program, our initial product was characterized in direct collaboration with Prof. Ariel Tenenbaum, Head of the Child Development Department. Following the accelerator, Plectrum signed a Letter of Intent (LOI) with Hadassah Medical Center. We are currently co-designing our first clinical pilot in partnership with the hospital's occupational therapy team as part of our ongoing clinical integration.
Academic Partnership
Deep collaboration with leading medical researchers and practitioners ensures clinical relevance and scientific rigor.
Active Protocols
Multiple clinical validation studies currently in progress across various therapeutic applications and patient populations.
Evidence-Based
Committed to peer-reviewed publication and regulatory approval pathways for maximum market credibility.
Shape the Future of Tactile Therapeutics
Join Plectrum’s mission to bridge the "Tangibility Gap" in digital care. We are now accepting applications for our 2026 Clinical Pilot Program.
Secure your spot to experience the world’s first AI-driven haptic platform and lead the transition to objective, reimbursable sensory medicine.
or Scan the QR Code to join our journey
Our Team
Traction
4 Functional Protoypes:
SDK Support Android & windows OS, connected to XR.
LOI's signed with Hadassha Ein Kerem Hospital.
NDA's Signed with NILIT & Delta
Initial LLM characterization in collaboration with IBM
Pilot Program 2026
Recruiting organizations and institutions for pilot programs in Israel, the US and Europe
*. Images are for illustrative purposes only. Final product design may vary.
Investment Opportunity
Join Us in Revolutionizing Healthcare
Raising at this Round $1.7M
We're seeking strategic investors to accelerate clinical validation, scale production, and capture the massive telehealth market opportunity. Your investment will fund critical clinical trials, regulatory approvals, and initial market deployment.
Partner with us to bring the missing sense of touch to digital healthcare and transform therapeutic outcomes for millions of patients worldwide.
Gabriel Lev-Har, Founder & CEO
+972-52-680-8756
gabriel@plectrum.biz
©2026 by Plectrum.